Siga Technologies (SIGA) Raw Materials (2012 - 2025)
Siga Technologies' (SIGA) quarterly Raw Materials came in at $1.0 million in Q4 2025, up 655.05% on a YoY basis from $134535.0 in Q4 2024, and down 90.97% quarter-over-quarter from $11.3 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Raw Materials (2012 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Raw Materials for 7 consecutive years, with $1.0 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Raw Materials rose 655.05% year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2025 stood at $1.0 million (up 655.05% YoY), and the FY2025 full-year result was $1.0 million, up 655.05% from the prior year.
- Raw Materials eased to $1.0 million in Q4 2025 per SIGA's latest filing, from $11.3 million in the prior quarter.
- Across five years, Raw Materials topped out at $11.3 million in Q3 2025 and bottomed at $14908.0 in Q2 2021.
- Historically, Raw Materials has averaged $2.3 million across 5 years, with a median of $134535.0 in 2024.
- The sharpest annual moves came in 2021 and 2023: Raw Materials plunged 99.43% in 2021, then soared 38519.54% in 2023.
- Over 5 years, Raw Materials stood at $22047.0 in 2021, then jumped by 28795.46% to $6.4 million in 2022, then increased by 26.55% to $8.1 million in 2023, then sank by 98.33% to $134535.0 in 2024, then jumped by 655.05% to $1.0 million in 2025.
- According to Business Quant data, Raw Materials over the past three periods registered $1.0 million, $11.3 million, and $934297.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 11.25 Mn |
| Jun 30, 2025 | 934,297.00 |
| Mar 31, 2025 | 134,535.00 |
| Dec 31, 2024 | 134,535.00 |
| Sep 30, 2024 | 134,535.00 |
| Jun 30, 2024 | 134,535.00 |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 8.06 Mn |
| Sep 30, 2023 | 64,186.00 |
| Jun 30, 2023 | 4.04 Mn |
| Mar 31, 2023 | 8.51 Mn |
| Dec 31, 2022 | 6.37 Mn |
| Sep 30, 2022 | 22,047.00 |
| Jun 30, 2022 | 22,047.00 |
| Mar 31, 2022 | 22,047.00 |
| Dec 31, 2021 | 22,047.00 |
| Sep 30, 2021 | 14,908.00 |
| Jun 30, 2021 | 14,908.00 |
| Mar 31, 2021 | 2.63 Mn |